Step Therapy for Biologics: Understanding Fail-First Policies

Your doctor prescribes a biologic infusion. Your insurance company says no, try this cheaper drug first. That is step therapy in action, and it affects hundreds of thousands of patients every year. Also called “fail-first,” step therapy requires patients to try and fail on one or more medications before the insurer will cover the drug their physician originally prescribed. Here is how the process works, when exceptions apply, and what state laws may protect you.

What Is Step Therapy?

Step therapy is a utilization management tool used by insurance companies to control drug spending. Instead of covering the medication your doctor prescribes right away, the insurer requires that you first try one or more alternative drugs, usually less expensive options. Only after you have “failed” those alternatives, meaning they did not work or caused intolerable side effects, will the insurer approve coverage for the originally prescribed medication.

For infusion therapy patients, step therapy often means being required to try oral medications, subcutaneous injections, or older biologic agents before gaining access to the specific infusion therapy your specialist recommended. In conditions like CIDP, rheumatoid arthritis, or Crohn’s disease, this can mean weeks or months on medications that the treating physician already knows are unlikely to be effective for that particular patient.

How Step Therapy Works in Practice

A typical step therapy protocol might look like this:

1. Step 1: Try a conventional or generic medication for 30 to 90 days
2. Step 2: If Step 1 fails, try a preferred biologic or specialty drug for 60 to 90 days
3. Step 3: If Steps 1 and 2 fail, the insurer approves coverage for the originally prescribed medication

“Failure” is defined by the insurer, not the patient or the doctor. This can mean documented side effects, measurable disease progression, or lab results showing inadequate response. Vague reports of “not feeling better” are rarely sufficient. The insurer wants objective evidence in the medical record.

What makes this especially challenging for infusion therapy patients is the time involved. Unlike switching between two oral pills, transitioning between infusion drugs requires new prior authorizations, possible changes in infusion setting, and careful monitoring during the switch. Each step can take months.

The Real Impact on Patients

Step therapy sounds reasonable in theory. In practice, its effects on patients can be severe:

• Disease progression: Months on an ineffective medication can allow the underlying condition to worsen, sometimes irreversibly. A patient with CIDP who spends 90 days on an inadequate therapy may experience nerve damage that better treatment could have prevented.
• Side effects from unwanted medications: Patients are required to take drugs they may not need, exposing them to side effects with no therapeutic benefit. This is not a trivial concern when the required “step” medications include immunosuppressants or corticosteroids with significant long-term risks.
• Emotional and psychological toll: Being told that your doctor’s clinical judgment is overruled by an insurance protocol creates feelings of helplessness and frustration. For patients already coping with a serious diagnosis, this added burden is not insignificant.
• Financial burden: Even failed medications cost money. Copays, lab monitoring, specialist visits to document failure, and potential emergency care for worsening symptoms all accumulate during the step therapy period.

Requesting a Step Therapy Exception

Most insurance plans have a process for requesting exceptions to step therapy requirements. An exception may be granted when:

• The patient has already tried and failed the required step medications, even if under a different insurance plan
• The required step medication is contraindicated due to another medical condition, allergy, or drug interaction
• The patient’s condition is severe enough that delaying the prescribed treatment poses a serious health risk
• The patient was stable on the prescribed medication before switching insurance plans (sometimes called “continuity of care”)

To request an exception, your physician must submit clinical documentation explaining why the step therapy protocol is not appropriate for your specific case. A strong letter of medical necessity is essential. This letter should reference your treatment history, current disease severity, and peer-reviewed evidence supporting the prescribed medication.

State Laws Limiting Step Therapy

Growing patient advocacy has led many states to pass laws restricting step therapy practices. As of 2026, more than 30 states have enacted some form of step therapy reform. These laws vary significantly, but common protections include:

• Exception processes: Requiring insurers to establish clear, accessible processes for patients and physicians to request exemptions
• Response timelines: Setting maximum timeframes for insurers to respond to exception requests, often 72 hours for urgent cases
• Prior treatment recognition: Prohibiting insurers from requiring patients to re-try medications that previously failed
• Clinical override: Allowing physicians to override step therapy when they document that it is not in the patient’s best interest

California’s SB 1340, one of the most comprehensive step therapy reform laws, requires insurers to grant exceptions when the required drug is contraindicated, when the patient previously failed the step drug, when the patient is stable on the prescribed medication, or when the prescriber provides clinical evidence that the required step is likely to be ineffective. Several other states have modeled legislation after California’s approach.

Your Doctor’s Role in Fighting Step Therapy

Physicians are often as frustrated by step therapy as their patients. But some doctors push back more effectively than others. Here is what to ask your prescribing specialist:

• “Will you submit a step therapy exception request?” Not all physicians do this proactively. Asking directly ensures the process begins.
• “Can you document why the step drug is not appropriate for me?” The more specific and evidence-based the documentation, the stronger the exception request.
• “Will you do a peer-to-peer review if the exception is denied?” A conversation between your doctor and the insurer’s medical director can resolve denials that paperwork alone cannot.
• “Can you help me file an appeal?” If the exception request is denied, a formal appeal with additional clinical evidence is the next step. Learn about the full appeal process in the prior authorization guide.

Step therapy policies are not permanent obstacles. They are insurance protocols with defined exception pathways and legal limits. Patients who understand the system, work with their physicians, and know their state’s protections are far more likely to get the medication their doctor originally prescribed, and to get it without unnecessary delays.

No one should have to get sicker to prove a treatment is needed. If step therapy is standing between you and the right medication, there are tools to fight it. Use them.